October 3, 2023
Investment to expand cell line development capabilities and accelerate customer workflows, as part of its diverse and tailored antibody solutions Cambridge, UK, and Porto, Portugal: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the Cyto-Mine® platform has been selected by FairJourney Biologics, a world leading end-to-end antibody partner, providing [...]
October 3, 2023
Singapore: A*STAR’s Genome Institute of Singapore (GIS), NanoString® Technologies, Inc. (NASDAQ: NSTG), and Next Level Genomics (NLG), today announced the establishment of a joint laboratory in Singapore focusing on the application of spatial biology to identify biomarkers that can predict disease progression and treatment response. The new lab, called the SpACE-Dx lab (Spatial Atlas of Clinical Evolution of Disease), [...]
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
October 3, 2023
SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Mark Buck as senior vice president, operations. Mr. Buck brings experience improving manufacturing efficiency and driving revenue and margin through managing supply chain and operations, including planning, quality, [...]
Bruker Completes Acquisition of PhenomeX
October 3, 2023
BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools, for $108 million in cash. Bruker announced the agreement to acquire PhenomeX on August 17, 2023. PhenomeX is a functional cell biology company that provides single-cell biology research tools to deliver [...]
October 3, 2023
Automata’s technology reduces drug development and testing timelines, costs and error rates – fundraise underlines strong investor & industry endorsement of its potential. Enables expansion of commercialisation strategy for efficiency-driving and capacity solving lab automation technology to the life sciences sector a leading automation company powering life sciences labs, has raised $40m to accelerate its [...]
Bruker Introduces Next-Generation Nanomechanical Test System
October 2, 2023
Hysitron TI 990 Enables Materials Characterization with New Levels of Nanoindentation Performance COLUMBUS, Ohio – At the annual Materials Science and Technology (MS&T23) conference, Bruker Corporation (Nasdaq: BRKR) today announced the release of the Hysitron TI 990 TriboIndenter®, which brings superior levels of performance, automation, and productivity to nanomechanical testing. TI 990 is a comprehensive advancement of [...]
October 2, 2023
News Summary: Using Waters SYNAPT™ High-Definition Mass Spectrometer (HDMS), scientists at the University of San Agustin aspire to become a regional research hub for natural medicine drug discovery. Scientists will use the SYNAPT HDMS equipped with MALDI and DESI imaging technologies to identify whether drug substances and their metabolites reach their intended targets within liver, [...]
October 2, 2023
In 2021, AcouSort AB (publ) (”AcouSort”, “the Company”) received funding from Vinnova for the project IndiCell. The aim of the project is to enable the transfer of novel stem cell treatments from research to a clinical setting. The project is planned to run over five years and generate revenues of SEK 1.25 million to AcouSort. [...]
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
October 2, 2023
WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer (CCO), effective immediately. Mr. Loeillot served a combined 12 years with Cytiva (a Danaher company) and GE [...]
October 2, 2023
Appointment of Vincent Smith, PhD, as Chief Technology Officer and Jessica Rich as VP Business Development Follows Broken String’s successful $15M Series A fundraising round in September 20231 Will support development and commercialization strategy for INDUCE-seq DNA break-mapping platform Cambridge, UK -- Broken String Biosciences (“Broken String”), a genomics company building a technology platform to [...]
